Mark Emalfarb
Founder at DYADIC INTERNATIONAL, INC.
Net worth: 8 M $ as of 2024-03-30
Profile
Mark A.
Emalfarb is the founder of Dyadic International, Inc., which was founded in 1979.
He currently holds the position of President, Chief Executive Officer & Director at Dyadic International, Inc. He is also the Chairman & Chief Executive Officer at Dyadic International (USA), Inc. and the Director at Biotechnology Development for Industry in Pharmaceuticals SLU.
Mr. Emalfarb completed his undergraduate degree at the University of Iowa in 1977.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
DYADIC INTERNATIONAL, INC.
16.16% | 2024-03-12 | 4,656,947 ( 16.16% ) | 8 M $ | 2024-03-30 |
Mark Emalfarb active positions
Companies | Position | Start |
---|---|---|
DYADIC INTERNATIONAL, INC. | Founder | 1978-12-31 |
Dyadic International (USA), Inc.
Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Chief Executive Officer | 2011-10-04 |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Director/Board Member | 2017-09-12 |
Training of Mark Emalfarb
University of Iowa | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
DYADIC INTERNATIONAL, INC. | Health Services |
Private companies | 2 |
---|---|
Dyadic International (USA), Inc.
Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Health Technology |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Commercial Services |
- Stock Market
- Insiders
- Mark Emalfarb